These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 33951350)
1. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. Buisson A; Nancey S; Manlay L; Rubin DT; Hebuterne X; Pariente B; Fumery M; Laharie D; Roblin X; Bommelaer G; Pereira B; Peyrin-Biroulet L; Vuitton L; United European Gastroenterol J; 2021 Jun; 9(5):552-560. PubMed ID: 33951350 [TBL] [Abstract][Full Text] [Related]
2. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease. Gisbert JP; Chaparro M Drugs; 2023 Sep; 83(13):1179-1205. PubMed ID: 37505446 [TBL] [Abstract][Full Text] [Related]
3. Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease. Boube M; Laharie D; Nancey S; Hebuterne X; Fumery M; Pariente B; Roblin X; Peyrin-Biroulet L; Minet-Quinard R; Pereira B; Bommelaer G; Buisson A; Dig Liver Dis; 2020 Jul; 52(7):740-744. PubMed ID: 32444250 [TBL] [Abstract][Full Text] [Related]
4. Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort. Azzam N; AlRuthia Y; Al Thaher A; Almadi M; Alharbi O; Altuwaijri M; Alshankiti S; Alanazi M; Alanazi A; Aljebreen A; Regueiro M Saudi J Gastroenterol; 2022; 28(3):201-208. PubMed ID: 35042320 [TBL] [Abstract][Full Text] [Related]
5. Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies. Rivière P; Vermeire S; Irles-Depe M; Van Assche G; Rutgeerts P; Denost Q; Wolthuis A; D'Hoore A; Laharie D; Ferrante M Clin Gastroenterol Hepatol; 2021 Apr; 19(4):713-720.e1. PubMed ID: 32272248 [TBL] [Abstract][Full Text] [Related]
6. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. Papamichael K; Archavlis E; Lariou C; Mantzaris GJ J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843 [TBL] [Abstract][Full Text] [Related]
7. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial. Bommelaer G; Laharie D; Nancey S; Hebuterne X; Roblin X; Nachury M; Peyrin-Biroulet L; Fumery M; Richard D; Pereira B; Goutte M; Buisson A; Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1553-1560.e1. PubMed ID: 31470175 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]. Geldof J; Truyens M; Hanssens M; Van Gucht E; Holvoet T; Elorza A; Bouillon V; Barros S; Martins V; Argyriou K; Potamianos S; Diculescu M; Stroie T; Bossuyt P; Moens A; Theodoraki E; Koutroubakis IE; Pedro J; Fernandes S; Nikolaou P; Karmiris K; Baert FJ; Ferreiro-Iglesias R; Peeters H; Claeys S; Casanova MJ; Eder P; Porter RJ; Arnott I; Karakan T; Mesonero F; Revés J; Van Dyck E; Jauregui-Amezaga A; Mañosa M; Rivière P; Marquez Mosquera L; Portela F; Pimentel R; Lobaton T J Crohns Colitis; 2024 Aug; 18(8):1202-1214. PubMed ID: 38243807 [TBL] [Abstract][Full Text] [Related]
9. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence. Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G; J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532 [TBL] [Abstract][Full Text] [Related]
10. Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial. López-Sanromán A; Vera-Mendoza I; Domènech E; Taxonera C; Vega Ruiz V; Marín-Jiménez I; Guardiola J; Castro L; Esteve M; Iglesias E; Ceballos D; Martínez-Montiel P; Gisbert JP; Mínguez M; Echarri A; Calvet X; Barrio J; Hinojosa J; Martín-Arranz MD; Márquez-Mosquera L; Bermejo F; Rimola J; Pons V; Nos P; J Crohns Colitis; 2017 Oct; 11(11):1293-1301. PubMed ID: 28402454 [TBL] [Abstract][Full Text] [Related]
11. Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease. Macaluso FS; Grova M; Mocciaro F; Di Mitri R; Privitera AC; Distefano ME; Vitello A; Camilleri S; Ferracane C; Pluchino D; Belluardo N; Giangreco E; Fries W; Viola A; Cappello M; D'Amato L; Bertolami C; Ventimiglia M; Renna S; Casà A; D'Antonio E; De Vivo S; Orlando A; J Gastroenterol Hepatol; 2023 Sep; 38(9):1503-1509. PubMed ID: 37148148 [TBL] [Abstract][Full Text] [Related]
12. Azathioprine Plus Exclusive Enteral Nutrition Versus Azathioprine Monotherapy for the Prevention of Postoperative Recurrence in Patients with Crohn's Disease: An Open-Label, Single-Centre, Randomized Controlled Trial. Duan M; Lu M; Diao Y; Cao L; Wu Q; Liu Y; Gong J; Zhu W; Li Y J Crohns Colitis; 2024 Aug; 18(7):1113-1121. PubMed ID: 38253914 [TBL] [Abstract][Full Text] [Related]
13. Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry. Mañosa M; Fernández-Clotet A; Nos P; Martín-Arranz MD; Manceñido N; Carbajo A; Hinojosa E; Hernández-Camba A; Muñoz-Pérez R; Boscá-Watts M; Calvo M; Sierra-Ausín M; Sánchez-Rodríguez E; Barreiro-de Acosta M; Núñez-Alonso A; Zabana Y; Márquez L; Gisbert JP; Guardiola J; Sáinz E; Delgado-Guillena P; Busquets D; van Domselaar M; Girona E; Lorente R; Casas-Deza D; Huguet JM; Maestro S; Cabello MJ; Castro J; Iborra M; Cañete F; Calafat M; Domènech E; Dig Liver Dis; 2023 Jan; 55(1):46-52. PubMed ID: 35948459 [TBL] [Abstract][Full Text] [Related]
14. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial. Mañosa M; Cabré E; Bernal I; Esteve M; Garcia-Planella E; Ricart E; Peñalva M; Cortes X; Boix J; Piñol M; Gassull MA; Domènech E Inflamm Bowel Dis; 2013 Aug; 19(9):1889-95. PubMed ID: 23689809 [TBL] [Abstract][Full Text] [Related]
15. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection. Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032 [TBL] [Abstract][Full Text] [Related]
16. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease. Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500 [TBL] [Abstract][Full Text] [Related]
17. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385 [TBL] [Abstract][Full Text] [Related]
18. Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study. Zabana Y; Mañosa M; Cabré E; Bernal I; Marín L; Lorenzo-Zúñiga V; Moreno V; Boix J; Domènech E J Gastroenterol Hepatol; 2014; 29(7):1413-7. PubMed ID: 24627958 [TBL] [Abstract][Full Text] [Related]
19. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence. Bachour SP; Shah RS; Joseph A; Syed H; Ali AH; Rieder F; Barnes EL; Axelrad J; Holubar SD; Regueiro M; Cohen BL; Click BH J Clin Gastroenterol; 2024 Sep; 58(8):810-817. PubMed ID: 38019054 [TBL] [Abstract][Full Text] [Related]
20. Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study. Le Cosquer G; Altwegg R; Rivière P; Bournet B; Boivineau L; Poullenot F; Bozon A; Buscail L; Laharie D; Gilletta C Dig Liver Dis; 2023 Jun; 55(6):727-734. PubMed ID: 36192340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]